Respiratory viral infections continue to pose a significant burden on healthcare systems worldwide, driving demand for effective antiviral therapies. Rising incidences of influenza, pneumonia, bronchiolitis, and other respiratory illnesses are encouraging pharmaceutical innovation and expanding treatment options. Growing awareness of early diagnosis and targeted treatment approaches has...